BusinessAccelerate Diagnostics Receives FDA Marketing Authorization for the Accelerate Pheno™ System and Accelerate PhenoTest™ BC KitBy Nasdaq OMXFeb 24, 2017, 2:46 AM UTC
BusinessAbiomed Surpasses 50,000 Impella® Patients Treated in the United StatesBy Nasdaq OMXFeb 23, 2017, 6:59 PM UTC
BusinessFibrocell Announces Dosing of First Patient in Phase I/II Clinical Trial of FCX-007 Gene Therapy for Treatment of Recessive Dystrophic Epidermolysis BullosaBy Nasdaq OMXFeb 23, 2017, 1:01 PM UTC
BusinessFibrocell Announces Dosing of First Patient in Phase I/II Clinical Trial of FCX-007 Gene Therapy for Treatment of Recessive Dystrophic Epidermolysis BullosaBy Nasdaq OMXFeb 23, 2017, 1:01 PM UTC
BusinessGeneSight® Psychotropic Test Demonstrated Substantial Cost Savings for Payers in New Study Published in Clinical TherapeuticsBy Nasdaq OMXFeb 23, 2017, 12:05 PM UTC
BusinessEarth Science Tech Initiates its Cannabis Cannabinoid-Based Composition of its 2 New Pharmaceutical Drugs and 3 Nutraceutical Patent StudiesBy Nasdaq OMXFeb 23, 2017, 11:45 AM UTC
BusinessWright Medical Group N.V. Reports 2016 Fourth Quarter and Full-Year Financial Results and Provides 2017 GuidanceBy Nasdaq OMXFeb 21, 2017, 9:06 PM UTC
BusinessWright Medical Group N.V. Reports 2016 Fourth Quarter and Full-Year Financial Results and Provides 2017 GuidanceBy Nasdaq OMXFeb 21, 2017, 9:06 PM UTC
